PFE Pfizer Inc

Price (delayed)

$39.58

Market cap

$220.76B

P/E Ratio

22.88

Dividend/share

$1.54

EPS

$1.73

Enterprise value

$258.81B

Sector: Healthcare
Industry: Drug Manufacturers - General

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights

PFE's debt is down by 37% from the previous quarter and by 24% YoY
Pfizer's revenue has increased by 10% QoQ
The quick ratio has soared by 77% YoY but it has contracted by 16% from the previous quarter
Pfizer's net income has decreased by 41% YoY but it has increased by 11% QoQ
The price to earnings (P/E) is 35% higher than the last 4 quarters average of 17.0 and 20% higher than the 5-year quarterly average of 19.1
Pfizer's equity has decreased by 3.1% QoQ

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.58B
Market cap
$220.76B
Enterprise value
$258.81B
Valuations
Price to earnings (P/E)
22.88
Price to book (P/B)
3.48
Price to sales (P/S)
5.25
EV/EBIT
25.64
EV/EBITDA
17.41
EV/Sales
6.18
Earnings
Revenue
$41.91B
EBIT
$10.09B
EBITDA
$14.87B
Free cash flow
$11.61B
Per share
EPS
$1.73
Free cash flow per share
$2.09
Book value per share
$11.38
Revenue per share
$7.54
TBVPS
$13.71
Balance sheet
Total assets
$154.23B
Total liabilities
$90.76B
Debt
$39.84B
Equity
$63.24B
Working capital
$9.15B
Liquidity
Debt to equity
0.63
Current ratio
1.35
Quick ratio
0.78
Net debt/EBITDA
2.56
Margins
EBITDA margin
35.5%
Gross margin
79.3%
Net margin
22.9%
Operating margin
17.9%
Efficiency
Return on assets
5.7%
Return on equity
14.9%
Return on invested capital
9.9%
Return on capital employed
7.9%
Return on sales
24.1%
Dividend
Dividend yield
3.89%
DPS
$1.54
Payout ratio
89%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
1%
1 week
2.41%
1 month
10.22%
1 year
7.09%
YTD
7.53%
QTD
9.25%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$41.91B
Gross profit
$33.22B
Operating income
$7.49B
Net income
$9.62B
Gross margin
79.3%
Net margin
22.9%
The company's operating margin has surged by 198% QoQ and by 116% YoY
The operating income has soared by 120% YoY
PFE's net margin is down by 42% YoY
Pfizer's net income has decreased by 41% YoY but it has increased by 11% QoQ

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
P/E
22.88
P/B
3.48
P/S
5.25
EV/EBIT
25.64
EV/EBITDA
17.41
EV/Sales
6.18
Pfizer's EPS has decreased by 41% YoY but it has increased by 11% from the previous quarter
The price to earnings (P/E) is 35% higher than the last 4 quarters average of 17.0 and 20% higher than the 5-year quarterly average of 19.1
PFE's P/B is 20% above its last 4 quarters average of 2.9 and 5% above its 5-year quarterly average of 3.3
Pfizer's equity has decreased by 3.1% QoQ
PFE's P/S is 14% above its 5-year quarterly average of 4.6 and 9% above its last 4 quarters average of 4.8
Pfizer's revenue has increased by 10% QoQ

Efficiency

How efficient is Pfizer business performance
The company's return on invested capital fell by 49% YoY but it rose by 36% QoQ
The ROE fell by 44% YoY but it rose by 10% QoQ
Pfizer's ROA has decreased by 43% YoY but it has increased by 14% from the previous quarter
Pfizer's ROS has decreased by 41% YoY but it has increased by 19% from the previous quarter

Dividends

What is PFE's dividend history
DPS
$1.54
Dividend yield
3.89%
Payout ratio
89%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 70% greater than its total liabilities
The quick ratio has soared by 77% YoY but it has contracted by 16% from the previous quarter
The current ratio has soared by 53% YoY but it has contracted by 3.6% from the previous quarter
PFE's debt is 37% less than its equity
PFE's debt is down by 37% from the previous quarter and by 24% YoY
The debt to equity has contracted by 35% from the previous quarter and by 24% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.